FDA Label for Erlotinib
View Indications, Usage & Precautions
Erlotinib Product Label
The following document was submitted to the FDA by the labeler of this product Cadila Healthcare Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
Erlotinib Tablets, 25 mg
30 tablets
NDC 70771-1521-3
Rx only
Erlotinib Tablets, 100 mg
30 tablets
NDC 70771-1522-3
Rx only
Erlotinib Tablets, 150 mg
30 tablets
NDC 70771-1523-3
Rx only
* Please review the disclaimer below.